This month, we had the honor of welcoming Lehendakari Imanol Pradales and key members of his government team to our facilities; Mikel Jauregi, Minister of Industry, Energy Transition and Sustainability; Juan Ignacio Pérez Iglesias, Minister of Science, University, and Innovation; and Jaione Ganzarain, Deputy Minister of Technology, Innovation, and Digital Transformation.
During their visit, we had the opportunity to share Viralgen’s mission of bringing advanced treatments to those who need them most, to showcase the science that takes place in our laboratories and give insights on AAVs (Adeno-Associated Virus vectors) manufacturing process, critical to gene therapies.
We are deeply grateful to have hosted these important visitors/ stakeholders and appreciate the continuous support critical for developing innovative therapies in the Basque country. This visit strengthens our commitment to health and innovation, as we work together to advance progress in the field of gene therapies.
News
September 26, 2024
Visit of Lehendakari Imanol Pradales and his team to Viralgen facilities: A step forward in advancing gene therapies
Explore more
Resources
Webinar: What Comes Next? Industry Takeaways from FDA’s Cell and Gene Therapy Listening Session
The US Food and Drug Administration’s Office of Therapeutic Products (OTP) convened a public listening session on September 18, 2025, asking the cell and gene therapy (CGT) community how prior knowledge can be leveraged to accelerate the development...
READ MORE
October 17, 2025
News
AskBio Announces 6 Presentations at the European Society of Gene and Cell Therapy 32nd Annual Meeting
One oral presentation and five poster presentations will highlight exciting progress in AskBio’s pipeline and advancements in the company’s manufacturing technologies Research Triangle Park, N.C.– OCTOBER 2, 2025 – AskBio Inc. (AskBio), a gene...
READ MORE
October 02, 2025
Insights
Harnessing AI for Faster and More Efficient Development & Manufacturing of Life-Changing Gene Therapies
Authors: María Iglesias, Head of Digital & IT Jens Keune, Data Science & Digital Product Manager Abstract As the biopharmaceutical landscape evolves, the integration of Artificial Intelligence (AI) into gene therapy manufacturing is increasingly...
READ MORE
July 28, 2025